Table 2.
B-FFE | T1W | T2W | CT | P | |
---|---|---|---|---|---|
Consolidation | 18/40 (45) | 18/40 (45) | 18/40 (45) | 19/40 (47.5) | 1.000 |
Ground glass appearance | 7/40 (17.5) | 9/40 (22.5) | 9/40 (22.5) | 14/40 (35) | 0.324 |
Patchy increased density | 3/40 (7.5) | 3/40 (7.5) | 3/40 (7.5) | 3/40 (7.5) | 1.000 |
Cavity | 4/40 (10) | 4/40 (10) | 4/40 (10) | 6/40 (15) | 0.921 |
Bronchodilation | 2/40 (5) | 3/40 (7.5) | 3/40 (7.5) | 4/40 (10) | 0.975 |
Peribronchial thickening | 3/40 (7.5) | 4/40 (10) | 3/40 (7.5) | 5/40 (12.5) | 0.933 |
Interlobular septal thickening | 0/40 (0) | 0/40 (0) | 0/40 (0) | 1/40 (2.5) | 1.000 |
Pericardial effusion | 3/40 (7.5) | 3/40 (7.5) | 3/40 (7.5) | 3/40 (7.5) | 1.000 |
Pleural thickening | 2/40 (5) | 2/40 (5) | 2/40 (5) | 3/40 (7.5) | 1.000 |
Air-crescent sign | 1/40 (2.5) | 3/40 (7.5) | 3/40 (7.5) | 4/40 (10) | 0.690 |
Reverse halo sign | 1/40 (2.5) | 1/40 (2.5) | 1/40 (2.5) | 1/40 (2.5) | 1.000 |
Pleural effusion | 17/40 (42.5) | 17/40 (42.5) | 17/40 (42.5) | 14/40 (35) | 0.902 |
Tree-in-bud nodules | 2/40 (5) | 2/40 (5) | 2/40 (5) | 14/40 (35) | <0.001 |
Centrilobular nodules | 1/40 (2.5) | 1/40 (2.5) | 1/40 (2.5) | 12/40 (30) | <0.001 |
Halo sign | 7/40 (17.5) | 20/40 (50) | 23/40 (57.5) | 26/40 (65) | 0.001 |
Data are presented as n/N (%).
CT, computed tomography; MRI, magnetic resonance imaging; B-FFE, balanced fast field echo; T1W, T1-weighted imaging; T2W, T2-weighted imaging.